UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Rathbones Group PLC

Rathbones Group PLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 31.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 237,395 shares of the healthcare conglomerate’s stock after purchasing an additional 56,288 shares during the quarter. Rathbones Group PLC’s holdings in UnitedHealth Group were worth $120,089,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the business. NewSquare Capital LLC bought a new position in UnitedHealth Group in the fourth quarter worth about $25,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at $28,000. Aster Capital Management DIFC Ltd acquired a new position in UnitedHealth Group during the 4th quarter valued at about $30,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. Finally, Promus Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at approximately $32,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH opened at $524.94 on Monday. The company’s 50 day simple moving average is $509.24 and its 200-day simple moving average is $541.85. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a market capitalization of $480.17 billion, a P/E ratio of 33.87, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the business posted $5.83 earnings per share. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is presently 54.19%.

Wall Street Analyst Weigh In

UNH has been the topic of a number of recent analyst reports. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research note on Friday, January 10th. Barclays lowered their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Truist Financial reduced their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $629.32.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.